<?xml version="1.0" encoding="UTF-8"?>
<p>Of 788 specific viral infections (726 primary infections and 62 recurrent infections) in 631 (80.1%) episodes therapies were performed: 583 (92.4%) pharmacotherapies and 48 (7.6%) symptomatic therapies. In all episodes of HHV-6, VZV, HPIV, HSV, hMPV infections, and in 97.6% of CMV, 92.6% FLUAV, 81.7% EBV, 60.0% ADV and 53.0% BKV infectious episodes specific antiviral pharmacotherapy was used. No specific pharmacotherapy was used for RV, RhV, NoV, PVB19 and HBV. The most frequent symptomatic therapies were used in RV (19/48), ADV (10/48), BKV (5/48) infections (
 <xref rid="T0001" ref-type="table">Table 1</xref>). The median time of treatment of specific viral infection range from 7 days for EBV, RV, FLUAV, RhV, NoV to 22.5 days for BKV and 24 days for CMV infections (
 <underline>
  <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=224291.docx" xmlns:xlink="http://www.w3.org/1999/xlink">Supplementary Table 2</ext-link>
 </underline>).
</p>
